Copyright

doi.org/10.4049/jimmunol.1502024, hdl.handle.net/1765/93481
Journal of Immunology
Erasmus MC: University Medical Center Rotterdam

Kunert, A., van Brakel, M., van Steenbergen-Langeveld, S., Da Silva, M. (Marvin), Coulie, P., Lamers, C., … Debets, R. (2016). MAGE-c2-specific TCRs combined with epigenetic drug-enhanced antigenicity yield robust and tumor-selective T cell responses. Journal of Immunology, 197(6), 2541–2552. doi:10.4049/jimmunol.1502024